TrialHead & neck2016

Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma.

Jessica L Geiger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.